Hospice controlled substance law sits at the intersection of the federal Controlled Substances Act, DEA regulations, and the Medicare Conditions of Participation at 42 CFR 418.106. Together these rules govern who may prescribe opioids and other scheduled drugs for a hospice patient, how those drugs are stored and transported, what records the hospice must keep, when a loss must be reported, and how unused medication is destroyed, whether it sits in a facility cabinet or on a deceased patient’s kitchen counter. A violation at any point in that chain can cost the hospice its Medicare certification and expose individual staff to federal criminal charges.
Who Can Prescribe Controlled Substances for a Hospice Patient
Two authorizations are required before anyone writes a controlled substance prescription in hospice: a DEA registration and a state license that permits controlled substance activity.1Drug Enforcement Administration. Practitioner’s Manual – Section III Registration Requirements DEA registration is state-specific: a prescriber practicing in two states needs a separate DEA registration in each, because the federal registration rides on the state license.2Drug Enforcement Administration. Registration Q&A – Diversion Control Division
Under 42 CFR 418.106, drugs may be ordered for a hospice patient only by a physician, a nurse practitioner acting within the state’s scope of practice, or a physician assistant who serves as the patient’s attending physician and is not employed by the hospice.3eCFR. 42 CFR 418.106 – Drugs and Biologicals, Medical Supplies, and Durable Medical Equipment
Prescription Rules by Schedule
The controlled substances used in hospice fall into Schedules II through V, and the schedule dictates how prescriptions may be written, transmitted, and refilled.4Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances Schedule II drugs, which include the opioids at the core of hospice pain management, cannot be refilled. Schedule III, IV, and V drugs may be refilled up to five times within six months of the original date.5Office of the Law Revision Counsel. 21 USC 829 – Prescriptions
Every prescription must include the date issued, the patient’s full name and address, the drug name, strength, dosage form, quantity, directions for use, and the prescriber’s name, address, and DEA number. The prescriber signs it on the day it is issued.6eCFR. 21 CFR 1306.05 – Manner of Issuance of Prescriptions
Faxed Schedule II Prescriptions
Hospice has a specific exception to the normal Schedule II written-prescription rule. A prescriber or their agent may fax a Schedule II narcotic prescription directly to the pharmacy for a patient enrolled in a Medicare-certified or state-licensed hospice program, and the fax itself serves as the original prescription. The prescription must note that the patient is a hospice patient.7eCFR. 21 CFR 1306.11 – Requirement of Prescription, Controlled Substances Listed in Schedule II
Emergency Oral Prescriptions
For an urgent symptom crisis with no written prescription available, a pharmacist may dispense a Schedule II drug on the prescriber’s oral authorization. The prescriber then has seven days to deliver a written follow-up prescription marked “Authorization for Emergency Dispensing” and dated to the oral order. If it does not arrive within seven days, the pharmacist must notify the DEA.7eCFR. 21 CFR 1306.11 – Requirement of Prescription, Controlled Substances Listed in Schedule II
Electronic Prescribing
The SUPPORT Act generally requires Schedule II through V controlled substances covered under Medicare Part D to be prescribed electronically. Compliance is measured against a 70 percent threshold of qualifying prescriptions per year, and prescribers who write 100 or fewer qualifying prescriptions annually are automatically exempt. Prescriptions written for patients in a long-term care facility will not count toward the compliance calculation until January 1, 2028. Home hospice patients are not covered by that carve-out, so prescribers serving them need electronic prescribing workflows in place now.8Centers for Medicare & Medicaid Services. CMS Electronic Prescribing for Controlled Substances Program
Comfort Kits
Comfort kits are pre-packaged sets of medications kept in a patient’s home for immediate symptom relief when a nurse is not present, typically containing small quantities of opioids, anti-anxiety drugs, and anti-nausea medications for predictable crises like breakthrough pain or respiratory distress. Most states require a hospice to hold specific authorization or a facility license before stocking and distributing these kits, and the contents and access rules vary by jurisdiction.
The controlled substances in a comfort kit generally remain the property of the dispensing pharmacy or hospice until they are actually administered. The hospice therefore carries accountability for every dose in the kit, and unused medications must be tracked and eventually returned or destroyed under the disposal rules discussed below.
Storage and Transport
A hospice that provides inpatient care in its own facility must store all Schedule II through V drugs in locked compartments inside a broader secure storage area, with access limited to staff authorized to administer controlled substances.3eCFR. 42 CFR 418.106 – Drugs and Biologicals, Medical Supplies, and Durable Medical Equipment When a patient care area is unstaffed, both controlled and non-controlled substances should be locked.
In the home, physical security falls to the patient and caregiver, but the hospice is responsible for making sure they know what to do. That means clear instructions on storing medications away from other household members and visitors, usually in a locked box or cabinet, plus ongoing assessment of diversion risk starting at admission.
For nurses carrying medications to and from a patient’s home, federal security regulations require that shipping containers not indicate they hold controlled substances and that registrants guard against in-transit theft.9eCFR. 21 CFR Part 1301 – Security Requirements In practice: unmarked locked containers, never visible in a vehicle.
Recordkeeping and Inventory
Every controlled substance must be tracked from acquisition to administration, return, or destruction. A hospice providing inpatient care must maintain current and accurate records of the receipt and disposition of all controlled drugs, and every administered dose belongs in the patient’s clinical record with date, time, quantity, and the identity of the person who gave it.3eCFR. 42 CFR 418.106 – Drugs and Biologicals, Medical Supplies, and Durable Medical Equipment
Controlled substance records, including inventories and dispensing logs, must be kept readily available for DEA inspection for at least two years from the date of the record.10eCFR. 21 CFR Part 1304 – Records and Reports of Registrants Every registrant must also complete a full physical inventory of all controlled substances on hand at least once every two years, known as the biennial inventory.11eCFR. 21 CFR 1304.11 – Inventory Requirements Many hospices anchor it to a consistent annual date to keep the timing clean. Routine reconciliation between records and drugs on hand is where most diversion gets caught; a mismatch needs to be investigated before it becomes a reportable loss.
Reporting Theft or Significant Loss
When controlled substances go missing, the hospice must give written notification to the local DEA Field Division Office within one business day of discovery.12Federal Register. Reporting Theft or Significant Loss of Controlled Substances A completed DEA Form 106 must then be submitted electronically to the same office within 45 calendar days; paper copies are no longer accepted.13Drug Enforcement Administration. Theft/Loss Reporting
Not every discrepancy triggers a report. The DEA distinguishes minor variances from “significant” losses and advises weighing several factors together rather than applying a single threshold:14Drug Enforcement Administration. Theft or Loss Q&A
- Quantity relative to the size of the operation.
- Type of drug, with Schedule II opioids drawing more concern than Schedule V preparations.
- Pattern, since repeated small shortages can signal systematic diversion.
- Whether the loss ties to identifiable individuals or events.
- Local diversion trends for the missing substance.
State boards of pharmacy often impose their own reporting requirements on timelines that may be shorter or longer than the federal one-business-day window, so compliance teams should check both.
Disposal of Unused Controlled Substances
Disposal splits along two tracks: drugs held by the hospice as a registered entity, and drugs held by the patient or, after death, the family.
Hospice Inventory
Destroying controlled substances from hospice inventory follows DEA registrant disposal procedures. Two hospice employees must personally handle or observe the handling of the drug and witness its destruction until it is rendered “non-retrievable,” meaning its physical or chemical state has been permanently and irreversibly altered so it can never be used as a controlled substance again.15eCFR. 21 CFR 1317.95 – Destruction Procedures16eCFR. 21 CFR 1300.05 – Definitions Relating to the Disposal of Controlled Substances The destruction is documented on DEA Form 41, which both witnesses sign under penalty of perjury.17Drug Enforcement Administration. DEA Form 41 Alternatively, the hospice can transfer the substances to a reverse distributor or request assistance from the DEA’s local Special Agent in Charge.18eCFR. 21 CFR Part 1317 Subpart A – Disposal of Controlled Substances by Registrants
Patient Medications in the Home
The SUPPORT for Patients and Communities Act created a specific pathway for hospice staff to help dispose of a patient’s medications at the patient’s home. Under 21 USC 822(g)(5), an employee of a qualified hospice program may handle and dispose of controlled substances onsite, without holding an individual DEA registration, when the patient has died, the medication has expired, or (if the employee is the patient’s physician) the plan of care no longer calls for the drug.19Government Accountability Office. Preventing Drug Diversion: Disposal of Controlled Substances in Home Hospice Settings
To qualify, the employee must be a physician, physician assistant, nurse, or other person licensed to perform medical or nursing services, be employed by or arranged through the hospice, and be trained by the hospice in secure disposal. The hospice itself must have written disposal policies and must have provided those policies to the patient or representative when controlled substances were first ordered.
Some states require a witness for the disposal, and the acceptable witness (a family member or a second hospice employee, for example) varies by jurisdiction.20Government Accountability Office. Preventing Drug Diversion: Disposal of Controlled Substances in Home Hospice Settings The hospice records the drug name, dosage, quantity destroyed, method, date, and time.
Family Self-Disposal
Family members who keep possession of a deceased patient’s medications are “ultimate users” under the Controlled Substances Act and may dispose of the drugs themselves. FDA-authorized take-back programs and DEA-authorized mail-back pouches are the safest options. If neither is available, the FDA recommends mixing the medication with coffee grounds, dirt, or cat litter, sealing the mixture in a container, and placing it in the household trash. Certain high-risk opioids carry FDA instructions to flush them down the toilet instead. The hospice should walk the family through the options rather than leaving them to work it out.
Required Patient and Family Education
The Medicare Conditions of Participation put the education obligation on the hospice. When controlled drugs are first ordered, the hospice must provide a written copy of its policies on managing and disposing of controlled substances, discuss those policies with the patient or representative and family in language they understand, and document in the clinical record that both steps happened.3eCFR. 42 CFR 418.106 – Drugs and Biologicals, Medical Supplies, and Durable Medical Equipment The interdisciplinary team must also evaluate the patient’s and family’s ability to safely administer medications at home as part of the plan of care review. Where the team concludes the family cannot handle it safely, that finding drives a conversation about alternatives.
Penalties for Non-Compliance
Consequences for mishandling controlled substances in hospice run from administrative sanctions to federal criminal prosecution.
- CMS can revoke a hospice’s Medicare enrollment for noncompliance with the Conditions of Participation, and revocation automatically terminates the provider agreement, cutting off Medicare reimbursement. CMS can also revoke the enrollment of individual prescribers who show a pattern of abusive prescribing that threatens beneficiary safety.21eCFR. 42 CFR Part 424 – Conditions for Medicare Payment
- The DEA can revoke or suspend a registrant’s controlled substance authorization for Controlled Substances Act violations, including recordkeeping failures, storage deficiencies, or failure to report theft.
- Individual employees who divert controlled substances face federal criminal charges. A hospice nurse indicted for diverting morphine faced charges carrying up to 10 years in prison and a $250,000 fine.22U.S. Department of Justice. Registered Nurse Indicted on Drug Diversion Charge
- State boards of nursing and pharmacy can suspend or revoke the licenses of practitioners involved in diversion or negligent medication management.
Most enforcement actions grow out of documentation gaps rather than dramatic theft. An incomplete comfort kit log, a missed biennial inventory, or a discrepancy not reported within the one-business-day federal window are the findings that trigger cascading consequences.